{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:18:02Z","timestamp":1790320682096,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":2524,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1469-0691.2007.01858.x","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T17:29:04Z","timestamp":1202491744000},"page":"189-193","source":"Crossref","is-referenced-by-count":53,"special_numbering":"S1","title":["Orthodox and unorthodox clavulanate combinations against extended-spectrum \u03b2-lactamase producers"],"prefix":"10.1016","volume":"14","author":[{"given":"D.M.","family":"Livermore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl A","key":"10.1111\/j.1469-0691.2007.01858.x_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/31.suppl_A.9","article-title":"Determinants of the activity of \u03b2-lactamase inhibitor combinations","volume":"31","author":"Livermore","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jac\/dki124","article-title":"BSAC standardized disc susceptibility testing method (version 4)","volume":"56","author":"Andrews","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib3","series-title":"Performance standards for antimicrobial disk susceptibility tests","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of \u03b2-lactam antibiotics against Escherichia coli strains producing extended-spectrum \u03b2-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkh424","article-title":"Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum \u03b2-lactamases in the UK","volume":"54","author":"Woodford","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1086\/502687","article-title":"A nosocomial outbreak of Escherichia coli producing CTX-M-15 and OXA-30 \u03b2-lactamase","volume":"27","author":"Pai","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2006.07.008","article-title":"The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter","volume":"14","author":"Livermore","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/jac\/dkl217","article-title":"Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England","volume":"58","author":"Potz","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/35.1.7","article-title":"TEM- and SHV-derived extended-spectrum \u03b2-lactamases: relationship between selection, structure and function","volume":"35","author":"Du Bois","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jac\/dkl102","article-title":"Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-\u03b2-lactamase-producing Escherichia coli with amoxicillin\/clavulanate: case report and characterization of the isolate","volume":"57","author":"Lagace-Wiens","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib12","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodriguez-Ba\u00f1o","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.16.3.325","volume":"16","author":"Curtis","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijantimicag.2006.11.020","article-title":"Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory","volume":"29","author":"Woodford","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"suppl B","key":"10.1111\/j.1469-0691.2007.01858.x_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/24.suppl_B.23","article-title":"Clavulanate and \u03b2-lactamase induction","volume":"24","author":"Livermore","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/AAC.34.2.337","article-title":"Outer membrane permeability and \u03b2-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents","volume":"34","author":"Nikaido","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib17","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1128\/JCM.42.10.4769-4775.2004","article-title":"Dramatic increase in prevalence of fecal carriage of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain","volume":"42","author":"Valverde","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jac\/dki451","article-title":"Activity of mecillinam against ESBL producers in vitro","volume":"57","author":"Thomas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2007.01858.x_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jac\/dkm150","article-title":"In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes","volume":"60","author":"Mushtaq","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14604936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T23:46:31Z","timestamp":1557272791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14604936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":20,"alternative-id":["S1198743X14604936"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01858.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}